Yoshimura A - Search Results

1

CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation.

Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, Hoshino T, Kubo M, Yamashita A, Okabe M, Takeda K, Akira S, Matsumoto S, Toyonaga A, Sata M, Yoshimura A. Suzuki A, et al. Among authors: yoshimura a. J Exp Med. 2001 Feb 19;193(4):471-81. doi: 10.1084/jem.193.4.471. J Exp Med. 2001. PMID: 11181699 Free PMC article.

2

CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation.

Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, Miyajima A, Yoshimura A. Matsumoto A, et al. Among authors: yoshimura a. Blood. 1997 May 1;89(9):3148-54. Blood. 1997. PMID: 9129017 Free article.

3

A new protein containing an SH2 domain that inhibits JAK kinases.

Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A. Endo TA, et al. Among authors: yoshimura a. Nature. 1997 Jun 26;387(6636):921-4. doi: 10.1038/43213. Nature. 1997. PMID: 9202126

4

A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons.

Sakamoto H, Yasukawa H, Masuhara M, Tanimura S, Sasaki A, Yuge K, Ohtsubo M, Ohtsuka A, Fujita T, Ohta T, Furukawa Y, Iwase S, Yamada H, Yoshimura A. Sakamoto H, et al. Among authors: yoshimura a. Blood. 1998 Sep 1;92(5):1668-76. Blood. 1998. PMID: 9716595 Free article.

5

CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells.

Suzuki R, Sakamoto H, Yasukawa H, Masuhara M, Wakioka T, Sasaki A, Yuge K, Komiya S, Inoue A, Yoshimura A. Suzuki R, et al. Among authors: yoshimura a. Oncogene. 1998 Oct 29;17(17):2271-8. doi: 10.1038/sj.onc.1202143. Oncogene. 1998. PMID: 9811457

6

The CIS/JAB family: novel negative regulators of JAK signaling pathways.

Yoshimura A. Yoshimura A. Leukemia. 1998 Dec;12(12):1851-7. doi: 10.1038/sj.leu.2401238. Leukemia. 1998. PMID: 9844915 Review.

7

The CIS family: negative regulators of JAK-STAT signaling.

Yoshimura A. Yoshimura A. Cytokine Growth Factor Rev. 1998 Sep-Dec;9(3-4):197-204. doi: 10.1016/s1359-6101(98)00019-7. Cytokine Growth Factor Rev. 1998. PMID: 9918119 Review.

8

Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain.

Sasaki A, Yasukawa H, Suzuki A, Kamizono S, Syoda T, Kinjyo I, Sasaki M, Johnston JA, Yoshimura A. Sasaki A, et al. Among authors: yoshimura a. Genes Cells. 1999 Jun;4(6):339-51. doi: 10.1046/j.1365-2443.1999.00263.x. Genes Cells. 1999. PMID: 10421843 Free article.

9

Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice.

Matsumoto A, Seki Y, Kubo M, Ohtsuka S, Suzuki A, Hayashi I, Tsuji K, Nakahata T, Okabe M, Yamada S, Yoshimura A. Matsumoto A, et al. Among authors: yoshimura a. Mol Cell Biol. 1999 Sep;19(9):6396-407. doi: 10.1128/MCB.19.9.6396. Mol Cell Biol. 1999. PMID: 10454585 Free PMC article.

10

Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation.

Cassatella MA, Gasperini S, Bovolenta C, Calzetti F, Vollebregt M, Scapini P, Marchi M, Suzuki R, Suzuki A, Yoshimura A. Cassatella MA, et al. Among authors: yoshimura a. Blood. 1999 Oct 15;94(8):2880-9. Blood. 1999. PMID: 10515892 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,535 results

Search Page

Filters